Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes

Molecular Nutrition and Food Research

Volumn 58, Issue 5, 2014, Pages 931-941

  Xu, Manli ^a   Hu, Juanjuan ^a   Zhao, Wenwen ^b   Gao, Xuejiao ^b   Jiang, Cuihua ^c   Liu, Kang ^a   Liu, Baolin ^a   Huang, Fang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b University of Macau   (Macao)

^c Laboratory of Translational Medicine   (China)

Author keywords

Adenosine 5' monophosphate activated protein kinase; Adipocytes; Akt substrate of 160 kDa; Insulin resistance; Quercetin

Indexed keywords

GLUCOSE TRANSPORTER 4; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, MOUSE; NITRIC OXIDE; PROTEIN KINASE B; QUERCETIN; SLC2A4 PROTEIN, MOUSE; SMALL INTERFERING RNA; TBC1D4 PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; INSTITUTE FOR CANCER RESEARCH MOUSE; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; HOMEOSTASIS; I-KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED ICR; NITRIC OXIDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84899007613     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300510     Document Type: Article

References (35)

1. Kane, S., Sano, H., Liu, S. C., Asara, J. M. et al., A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 2002, 277, 22115-22118.
2. Roach, W. G., Chavez, J. A., Mîinea, C. P., Lienhard, G. E., Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem. J. 2007, 403, 353-358.
3. Sakamoto, K., Holman, G. D., Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol Metab. 2008, 295, E29-E37.
4. Holmes, B. F., Kurth-Kraczek, E. J., Winder, W. W., Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 1999, 87, 1990-1995.
5. Merrill, G. F., Kurth, E. J., Hardie, D. G., Winder, W. W., AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273, E1107-E1112.
6. Holmes, B. F., Sparling, D. P., Olson, A. L., Winder, W. W. et al., Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am. J. Physiol. Endocrinol Metab. 2005, 289, E1071-E1076.
7. Deshmukh, A., Coffey, V. G., Zhong, Z., Chibalin, A. V. et al., Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle. Diabetes 2006, 55, 1776-1782.
8. Thong, F. S., Bilan, P. J., Klip, A., The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007, 56, 414-423.
9. Treebak, J. T., Glund, S., Deshmukh, A., Klein, D. K. et al., AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 2006, 55, 2051-2058.
10. Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M., Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
11. Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B. et al., Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 1993, 268, 26055-26058.
12. Shoelson, S. E., Lee, J., Goldfine, A. B., Inflammation and insulin resistance. J. Clin. Invest. 2006, 116, 1793-1801.
13. Gual, P., Le Marchand-Brustel, Y., Tanti, J. F., Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87, 99-109.
14. Sag, D., Carling, D., Stout, R. D., Suttles, J., Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 2008, 181, 8633-8641.
15. Yang, Z., Kahn, B. B., Shi, H., Xue, B. Z., Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 2010, 285, 19051-19059.
16. Galic, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S. et al., Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 2011, 121, 4903-4915.
17. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L. et al., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2011, 293, 1673-1677.
18. Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012, 336, 918-922.
19. Kim, J. H., Kang, M. J., Choi, H. N., Jeong, S. M. et al., Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr. Res. Pract. 2011, 5, 107-111.
20. Jeong, S. M., Kang, M. J., Choi, H. N., Kim, J. H. et al., Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr. Res. Pract. 2012, 6, 201-207.
21. Chuang, C. C., Martinez, K., Xie, G., Kennedy, A. et al., Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr. 2011, 92, 1511-1521.
22. Anhê, G. F., Okamoto, M. M., Kinote, A., Sollon, C. et al., Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur. J. Pharmacol. 2012, 689, 285-293.
23. Strobel, P., Allard, C., Perez-Acle, T., Calderon, R. et al., Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J. 2005, 386, 471-478.
24. Nomura, M., Takahashi, T., Nagata, N., Tsutsumi, K. et al., Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol. Pharm. Bull. 2008, 31, 1403-1409.
25. Eid, H. M., Martineau, L. C., Saleem, A., Muhammad, A. et al., Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res. 2010, 54, 991-1003.
26. Shen, Y., Croft, K. D., Hodgson, J. M., Kyle, R. et al., Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK. Biochem. Pharmacol. 2012, 84, 1036-1044.
27. Liu, K., Luo, T., Zhang, Z., Wang, T. et al., Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway. J. Ethnopharmacol. 2011, 136, 473-479.
28. Blodgett, A. B., Kothinti, R. K., Kamyshko, I., Petering, D. H. et al., A fluorescence method for measurement of glucose transport in kidney cells. Diabetes Technol. Ther. 2011, 13, 743-751.
29. Chavez, J. A., Roach, W. G., Keller, S. R., Lane, W. S. et al., Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283, 9187-9195.
30. Sano, H., Kane, S., Sano, E., Mîinea, C. P. et al., Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003, 278, 14599-14602.
31. Eguez, L., Lee, A., Chavez, J. A., Miinea, C. P. et al., Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2005, 2, 263-272.
32. Salt, I. P., Connell, J. M., Gould, G. W., 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 2000, 49, 1649-1656.
33. Gaidhu, M. P., Perry, R. L., Noor, F., Ceddia, R. B., Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Mol. Endocrinol. 2010, 24, 1434-1440.
34. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A. et al., Local and systemic insulin resistance resulting from hepatic activation of IKKbeta and NF-kappaB. Nat. Med. 2005, 11, 183-190.
35. Lu, S., Kang, L., Fang, H., Xudan, G. et al., Opposite effects of quercetin, luteolin, and epigallocatechin gallate on insulin sensitivity under normal and inflammatory conditions in mice. Inflammation 2013, 36, 1-14.